Clinical Trial: Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07590219) titled 'Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity' on April 22.

Brief Summary: This randomized controlled trial evaluates the efficacy, safety, metabolic, and cardiovascular effects of liraglutide in children aged 6 to 12 years with severe obesity. Participants are randomized to receive liraglutide plus lifestyle intervention or lifestyle intervention alone for 6 months. In addition to primary outcomes related to weight loss and metabolic improvement, a predefined subgroup analysis evaluates cardiovascular function in participants receiving liraglutide using advanced echocardiographic techniques, including speckle...